What are you looking for?
Low-dose atropine did not significantly slow myopia progression in children with inherited retinal diseases (IRDs) after accounting for age-related changes, according to a study. Researchers analyzed 262 refractive examinations from...
Low-dose atropine did not significantly slow myopia progression in children with inherited retinal diseases (IRDs) after accounting for age-related changes, according to a study. Researchers analyzed 262 refractive examinations from...
Eva Kim, MD, of ICON Eyecare, spoke with Ophthalmology 360 at the 2026 ASCRS Annual Meeting about the ability to now use implantable collamer lenses (IOLs) in patients aged up...
Low-dose atropine (0.01%) slows myopia progression in children, with varying levels of effectiveness across different ethnic groups, according to a study. The analysis included 25 randomized controlled trials involving 4,374...
New subgroup analyses from the Phase 3 STAR trial presented at the 51st Annual Meeting of the American Association for Pediatric Ophthalmology and Strabismus show that SYD-101 0.01%, a low-dose...
Adult patients with myopia generally have positive attitudes toward refractive surgery, but their knowledge and postoperative care practices are limited, and greater knowledge is associated with better attitudes and behaviors....
In an episode of The Spotlight Series Podcast, hosted by Mario Nacinovich, Larissa Camejo, MD, speaks about patients with glaucoma and myopia. Dr. Camejo highlights the increased vulnerability of highly...
Repeated low-level red light (RLRL) therapy slowed myopia progression more than 1% atropine over 12 months, but showed slightly greater rebound in axial length after treatment stopped. The prospective, single-blinded...
A large cross-sectional study suggests that dietary patterns may be associated with myopia risk in children and adolescents. Researchers analyzed data from 24,797 participants enrolled in the Child and Adolescent...